Effects of Emodin Extracted from Chinese Herbs on Proliferation of Non-small Cell Lung Cancer and Underlying Mechanisms

被引:38
作者
He, Lin [1 ]
Bi, Juan-Juan [1 ]
Guo, Qian [1 ]
Yu, Yin [1 ]
Ye, Xiu-Feng [1 ]
机构
[1] Chongqing Med Univ, Dept Pathol, Inst Neurosci, Chongqing Key Lab Neurobiol, Chongqing, Peoples R China
关键词
Non-small lung cell cancer; emodin; ERCC1; Rad51; vacuolar degeneration; GENE-EXPRESSION; DOWN-REGULATION; IN-VITRO; RAD51; ERCC1; REPAIR; CYTOTOXICITY; SENSITIVITY; RESISTANCE; CISPLATIN;
D O I
10.7314/APJCP.2012.13.4.1505
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
To aim of this was to observe emodin-mediated cytotoxicity and its influence on Rad51 and ERCC1 expressionin non-small cell lung cancer (NSCLC). NSCLC cells were cultured in vitro with emodin at various concentrations (0, 25, 50, 75 and 100 mu mol/L) for 48h and the proliferation inhibition rate was determined by the MTT method. Then, NSCLC were treated with emodin (SK-MES-1 40 mu mol/L, A549 70 mu mol/L) or 20 mu mol/L U0126 (an ERK inhibitor) for 48 h, or with various concentrations of emodin for 48 h and the protein and mRNA expressions of ERCC1 and Rad51 were determined by RT-PCR and Western blot assay, respectively. Emodin exerted a suppressive effect on the proliferation of NSCLC in a concentration dependent manner. Protein and mRNA expression of ERCC1 and Rad51 was also significantly decreased with the dose. Vacuolar degeneration was observed in A549 and SK-MES-1 cell lines after emodin treatment by transmission electron microscopy. Emodin may thus inhibited cell proliferation in NSCLC cells by downregulation ERCC1 and Rad51.
引用
收藏
页码:1505 / 1510
页数:6
相关论文
共 24 条
[1]
Altaha R, 2004, INT J MOL MED, V14, P959
[2]
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine [J].
Ceppi, P. ;
Volante, M. ;
Novello, S. ;
Rapa, I. ;
Danenberg, K. D. ;
Danenberg, P. V. ;
Cambieri, A. ;
Selvaggi, G. ;
Saviozzi, S. ;
Calogero, R. ;
Papotti, M. ;
Scagliotti, G. V. .
ANNALS OF ONCOLOGY, 2006, 17 (12) :1818-1825
[3]
Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation [J].
Chen, Ruey-Shyang ;
Jhan, Jhih-Yuan ;
Su, Ying-Jhen ;
Lee, Wei-Ting ;
Cheng, Chao-Min ;
Ciou, Shih-Ci ;
Lin, Szu-Ting ;
Chuang, Show-Mei ;
Ko, Jen-Chung ;
Lin, Yun-Wei .
EXPERIMENTAL CELL RESEARCH, 2009, 315 (15) :2658-2672
[4]
Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo [J].
Chun-Guang, Wang ;
Jun-Qing, Yang ;
Bei-Zhong, Liu ;
Dan-Ting, Jin ;
Chong, Wang ;
Liang, Zhong ;
Dan, Zhu ;
Yan, Wu .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 627 (1-3) :33-41
[5]
Effects of emodin on gene expression profile in small cell lung cancer NCI-H446 cells [J].
Fu Zhong-yan ;
Han Jin-xiang ;
Huang Hai-yan .
CHINESE MEDICAL JOURNAL, 2007, 120 (19) :1710-1715
[6]
Emodin inhibits TNF-α-induced human aortic smooth-muscle cell proliferation via caspase- and mitochondrial-dependent apoptosis [J].
Heo, Sook-Kyoung ;
Yun, Hyun-Jeong ;
Park, Won-Hwan ;
Park, Sun-Dong .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 105 (01) :70-80
[7]
Emodin inhibits the growth of hepatoma cells: Finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells [J].
Hsu, Chin-Mu ;
Hsu, Yu-An ;
Tsai, Yuhsin ;
Shieh, Fa-Kuen ;
Huang, Su-Hua ;
Wan, Lei ;
Tsai, Fuu-Jen .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 392 (04) :473-478
[8]
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine [J].
Ko, Jen-Chung ;
Tsai, Min-Shao ;
Kuo, Ya-Hsun ;
Chiu, Yu-Fan ;
Weng, Shao-Hsing ;
Su, Ying-Chen ;
Lin, Yun-Wei .
BIOCHEMICAL PHARMACOLOGY, 2011, 81 (05) :680-690
[9]
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2 [J].
Ko, Jen-Chung ;
Su, Ying-Jhen ;
Lin, Szu-Ting ;
Jhan, Jhih-Yuan ;
Ciou, Shih-Ci ;
Cheng, Chao-Min ;
Chiu, Yu-Fan ;
Kuo, Ya-Hsun ;
Tsai, Min-Shao ;
Lin, Yun-Wei .
LUNG CANCER, 2010, 69 (02) :155-164
[10]
Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells [J].
Ko, Jen-Chung ;
Su, Ying-Jhen ;
Lin, Szu-Ting ;
Jhan, Jhih-Yuan ;
Ciou, Shih-Ci ;
Cheng, Chao-Min ;
Lin, Yun-Wei .
BIOCHEMICAL PHARMACOLOGY, 2010, 79 (04) :655-664